Perspectives on Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
- PMID: 35895050
- DOI: 10.1001/jamasurg.2022.2940
Perspectives on Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Comment in
-
Perspectives on Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer-Reply.JAMA Surg. 2022 Oct 1;157(10):970-971. doi: 10.1001/jamasurg.2022.2941. JAMA Surg. 2022. PMID: 35895070 No abstract available.
Comment on
-
Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.JAMA Surg. 2022 May 1;157(5):374-383. doi: 10.1001/jamasurg.2022.0143. JAMA Surg. 2022. PMID: 35262624 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical